How Can We Help?
Skip to content
Wire frame hand with test tube

Upcoming & Archived Events

Webinar: An Overview of Non CYP-Mediated Metabolism Pathways and In Vitro Evaluation Strategies

  • Apr 20, 2021
  • Webinar

Although cytochrome P450 (CYP)-mediated metabolism continues to be of major importance for a large proportion of small molecule new drug candidates, various methods in recent…

March 31st DDI Guidance Webinar with Access to a Panel of Drug Metabolism & DDI Experts

  • Mar 31, 2021
  • Webinar

Why should you follow DDI guidance even if you don’t have to? If you missed getting the answer to this question in November 2020 because…

Preclinical DILI Risk Assessment Strategies: Bile Acid-Dependent Hepatotoxicity & Mitochondrial Toxicity Assays

  • Mar 12, 2021
  • Webinar

As part of this year’s SOT Annual Meeting and ToxExpo, we will be including a special presentation as part of...

2C or Not 2C: CYP2C Induction Studies for Successful Preclinical Risk Assessment

  • Mar 2, 2021
  • Webinar

As a part of IND-enabling preclinical drug development studies companies are required to meet regulatory expectations to evaluate the induction...

In Vitro Cholestatic DILI & Mitochondrial Toxicity Studies to Assess Hepatotoxicity

  • Jan 26, 2021

This webinar was presented on Jan. 26, 2021 by Miki Fujishima, a manager in the Business Development Department at the...

2020 Holiday Wishes

  • Dec 11, 2020

Jingle cells, Jingle cells, Jingle all the way… to IND! Oh what fun it is to ride on reliable, high-quality...

DMDG Webinar – Comparison Between the Final FDA, EMA, and PMDA In Vitro DDI Guidance Documents: Are We Finally Harmonized?

  • Nov 19, 2020

Dr. Ogilvie offers his expert perspectives on major updates in the FDA’s Final Guidance for Industry and takes a magnifying glass to the differences between…

Presentation at 2020 ACT Meeting

  • Nov 11 - Nov 18, 2020

At 3pm on Nov. 13, Drs. Andrew Taylor and Pallavi Limaye will present “In Vitro ADME and Drug-Drug Interaction Considerations...

Poster at 2020 AAPS PharmSci 360 Meeting

  • Oct 26 - Nov 5, 2020

SEKISUI XenoTech will have a poster at this year’s virtual AAPS PharmSci 360 meeting from Oct. 26th-Nov. 5th, 2020. The...

Webinar: Hyaluronan (HA) Synthesis Inhibition Normalizes Hepatic Fibrogenic Features by Reducing Hepatic Stellate Cell Activation in Alcohol-Associated Liver Disease Models

  • Sep 22, 2020
  • Webinar

Presented by: Michele Pritchard, Ph.D., Associate Professor, University of Kansas Medical Center and Maciej Czerwinski, Ph.D., Director of Consulting, SEKISUI XenoTech In...

Want to see more webinars?

Check out the Webinars page in Access ADME to find upcoming and archived webinars presented by our drug metabolism & DDI experts

Wall of chemical formulas